A significant 4 SNP haplotype spanned the cancer pathway gene PFKM (phosphofructokinase, muscle), and homozygosity for this haplotype was more common in cases (19%) compared to carriers (7%) and controls (3%). The gene discussed is PFKM; the disease is cancer.